Ablative Solutions secures $91.4 million in Series D funding

Ablative Solutions is an American surgical medical device provider focused on providing an alternative to renal artery denervation (RDN) for the treatment of hypertension. Its technology involves endovascular catheters for renal artery denervation (RDN). Provides an effective, durable, cost-effective and safe alternative for the treatment of hypertension and other conditions. Recently announced the completion of the D round of financing of 91.4 million US dollars, led by BioStar.

This article is reproduced from: https://www.itjuzi.com/investevent/13280029
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.